More interestingly, AR activation has been linked to resistance to conventional non-surgical treatments for bladder cancer [12], including CDDP therapy [13,14,15], as well as intravesical bacillus Calmette-Guѐrin immunotherapy [16] and radiotherapy [17]. The gene discussed is AR; the disease is urinary bladder carcinoma.